home / stock / kdskf / kdskf news


KDSKF News and Press, Koninklijke DSM NV From 03/28/23

Stock Information

Company Name: Koninklijke DSM NV
Stock Symbol: KDSKF
Market: OTC
Website: dsm.com

Menu

KDSKF KDSKF Quote KDSKF Short KDSKF News KDSKF Articles KDSKF Message Board
Get KDSKF Alerts

News, Short Squeeze, Breakout and More Instantly...

KDSKF - I Smell Deep Value At International Flavors & Fragrances

2023-03-28 23:20:19 ET Summary International Flavors & Fragrances is a major player that holds market-leading positions in its fields of expertise. The last couple of years have been hard on the business and the market has derated it considerably both in absolute and relative ...

KDSKF - Royal DSM: Significant Execution Risk

2023-03-08 14:16:37 ET Summary DSM continues to engage in optimization of their product portfolio, which introduces execution risk related to integrating acquisitions, particularly with Firmenich due to its size. DSM expects inflation to be an ongoing problem, which may contribute...

KDSKF - Royal DSM 2022 Results: Better Than Feared

Summary Results for 2022 were mixed, and Q4 in particular was difficult for the company. Still, the results were better than we feared they could be given the headwinds. The company has demonstrated pricing power, which helped offset some of the negative inflationary impacts, but this h...

KDSKF - Koninklijke DSM N.V. 2022 Q4 - Results - Earnings Call Presentation

The following slide deck was published by Koninklijke DSM N.V. in conjunction with their 2022 Q4 earnings call. For further details see: Koninklijke DSM N.V. 2022 Q4 - Results - Earnings Call Presentation

KDSKF - Koninklijke DSM N.V. (KDSKF) Q4 2022 Earnings Call Transcript

Koninklijke DSM N.V. (KDSKF) Q4 2022 Earnings Conference Call February 16, 2023 8:00 AM ET Company Participants Dave Huizing – Head-Investor Relations Geraldine Matchett – Co-Chief Executive Officer Dimitri de Vreeze – Co-Chief Executive Officer ...

KDSKF - Koninklijke DSM N.V. reports FY results

Koninklijke DSM N.V. press release ( OTCPK:KDSKF ): FY Revenue of €8.39B (+15.4% Y/Y). Net profit of €1.71B For further details see: Koninklijke DSM N.V. reports FY results

KDSKF - Royal DSM Q3 Results: Good Organic Sales Growth, But Inflation Is Impacting Earnings

Summary Royal DSM delivered solid sales growth for the third quarter, but profit margins were impacted by inflation and energy costs in Europe. Given that the merger with Firmenich is getting closer, we share the expected merged financials and what a combined company could look li...

KDSKF - Royal DSM: Transformation Almost Complete, Shares Attractively Priced

Summary Royal DSM is becoming a pure-play in health, nutrition, and bio-science. Royal DSM has the most complete portfolio of nutritional ingredients, going from vitamins and minerals, to Stevia sweeteners, natural preservatives, and alternative proteins. We believe that after...

KDSKF - Finding Good Investments Via TdF Sponsorships

Summary Tadej Pogacar attempted a hat trick this year: a third Tour de France win. However, competitor Jonas Vingegaard and his team broke records and showed impressive form. The popularity of some stages this year may indicate a high viewership count, leading to favorable pub...

KDSKF - Royal DSM: Quality At A Price

Royal DSM has proven its resilience through the near-term macro challenges. Its upcoming merger with Firmenich also appears promising and could deliver upside going forward. At the current premium valuation multiple, though, I am neutral on the stock. Koninklijke DSM ( ...

Previous 10 Next 10